Abstract
Purpose
Taste and smell abnormalities (TSA) are common in patients receiving chemotherapy and may lead to altered nutritional intake, treatment withdrawal, and impaired quality of life. Lipid peroxidation in the oral cavity is one cause of TSA. Lactoferrin (LFN), an iron-binding salivary protein, reduces production of lipid oxidation byproducts and has been shown to reduce perception of unpleasant flavors. To assess the feasibility of LFN as a treatment for TSA, we conducted pilot investigations among patients with cancer who self-reported TSA following onset of chemotherapy. The primary objective was to assess change in subjective taste and smell perception from baseline to completion of 30 days of LFN supplementation.
Methods
Patients were treated with 750 mg LFN daily for 30 days and followed for an additional 30 days without LFN. TSA was measured via the taste and smell questionnaire (TSQ) including taste (score 0–10), smell (score 0–6), and composite scores (0–16) (0 = no TSA) at baseline, day 30, and day 60.
Results
A total of 26 patients enrolled; 19 remained on study at day 30 and 17 at day 60. Baseline mean TSQ scores were 6.5 (taste), 3.1 (smell), and 9.6 (composite). By day 30, mean composite TSQ score improved by 1.7 (p = 0.018); taste and smell improved by 0.6 (p = 0.062) and 1.1 (p = 0.042), respectively. From baseline to day 60, mean composite TSQ score improved by 3.8 (p < 0.0001); taste and smell improved by 1.9 (p = 0.001) and 1.8 (p = 0.003).
Conclusions
Further evaluation of LFN is warranted to determine its value for improving self-reported TSA among patients receiving chemotherapy.
Similar content being viewed by others
Data availability
Our research team has full control over all primary data and we agree to allow the journal to review the data if requested.
Code availability
N/A.
References
Epstein JB, Smutzer G, Doty RL (2016) Understanding the impact of taste changes in oncology care. Support Care Cancer
Spotten L et al. (2016) Subjective taste and smell changes in treatment-naive people with solid tumours. Support Care Cancer
Hovan AJ et al. (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer
Barnhart MK et al. (2018) Treatment toxicities and their impact on oral intake following non-surgical management for head and neck cancer: a 3-year longitudinal study. Support Care Cancer
Sevryugin O, Kasvis P, Vigano ML, Vigano A (2021) Taste and smell disturbances in cancer patients: a sco** review of available treatments. Support Care Cancer
Ömür-Özbek P, Dietrich AM, Duncan SE, Lee YW (2012) Role of lipid oxidation, chelating agents, and antioxidants in metallic flavor development in the oral cavity. J Agric Food Chem
Comeau TB, Epstein JB, Migas C (2001) Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer
Yamashita H et al. (2006) Taste dysfunction in patients receiving radiotherapy. Head Neck
Yamashita H et al. (2009) Umami taste dysfunction in patients receiving radiotherapy for head and neck cancer. Oral Oncol
Marín Caro MM, Laviano A, Pichard C (2007) Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care
Ruz M, Cavan K, Bettger W, Thompson L, Berry M, Gibson R (1991) Development of a dietary model for the study of mild zinc deficiency in human and evaluation of some biochemical and functional indices of zinc status. Am J Clin Nutr 53:1295–1303
Ripamonti C et al. (1998) A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer
Hoppe C, Kutschan S, Dörfler J, Büntzel J, Büntzel J, Huebner J (2021) Zinc as a complementary treatment for cancer patients: a systematic review. Clin Exp Med
Chi WJ et al. (2020) The effects of zinc on radiation-induced dysgeusia: a systematic review and meta-analysis. Support Care Cancer
Braud A, Boucher Y (2020) Taste disorder’s management: a systematic review. Clin Oral Investig
Wang A, Duncan SE, Lesser GJ, Ray WK, Dietrich AM (2018) Effect of lactoferrin on taste and smell abnormalities induced by chemotherapy: a proteome analysis. Food Funct
Kanyshkova TG et al. (2003) Multiple enzymic activities of human milk lactoferrin. Eur J Biochem
Oken MM et al. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol
Heald AE, Pieper CF, Schiffman SS (1998) Taste and smell complaints in HIV-infected patients. AIDS
CM L et al. (2014) Taste and smell disturbances after brain irradiation: a dose-volume histogram analysis of a prospective observational study. Pract Radiat Oncol
Hutton JL, Baracos VE, Wismer WV (2007) Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage
Doty RL, Frye RE, Agrawal U. Internal consistency reliability of the fractionated and
Blauwhoff-Buskermolen S et al. (2016) The assessment of anorexia in patients with cancer: cut-off values for the FAACT–A/CS and the VAS for appetite. Support. Care Cancer
Silva M, Melo A, Barbosa K, Pereira J, Alves P, Gomes D (2014) Evaluation of oral health status and quality of life of head and neck cancer patients after radiation therapy. Stomatol Glas Srb Dent J
Lockhart PB, Clark J (1994) Pretherapy dental status of patients with malignant conditions of the head and neck. Oral Surgery, Oral Med Oral Pathol
Berteretche MV, Dalix AM, D’Ornano AMC, Bellisle F, Khayat D, Faurion A (2004) Decreased taste sensitivity in cancer patients under chemotherapy. Support Care Cancer
Mirlohi S, Duncan SE, Harmon M, Case D, Lesser G, Dietrich AM (2015) Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumors. Clin Oral Investig
Metgud R, Bajaj S (2014) Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma. J Oral Sci
Schwartz M, Neiers F, Feron G, Canon F (2021) The relationship between salivary redox, diet, and food flavor perception. Frontiers in Nutrition
Dawes C et al. (2015) The functions of human saliva: a review sponsored by the World Workshop on Oral Medicine VI. Arch Oral Biol
Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease, and oxidative stress. J Biol Chem
Skolin I, Wahlin YB, Broman DA, Koivisto Hursti UK, Vikström Larsson M, Hernell O (2006) Altered food intake and taste perception in children with cancer after start of chemotherapy: perspectives of children, parents and nurses. Support Care Cancer
Wickham RS et al. (1999) Taste changes experienced by patients receiving chemotherapy. Oncol Nurs Forum
Bernhardson BM, Tishelman C, Rutqvist LE (2007) Chemosensory changes experienced by patients undergoing cancer chemotherapy: a qualitative interview study. J Pain Symptom Manage
Zabernigg A et al. (2010) Taste alterations in cancer patients receiving chemotherapy: a neglected side effect?. Oncologist
Heckel M, Stiel S, Ostgathe C (2015) Smell and taste in palliative care: a systematic analysis of literature. Eur Arch Otorhinolaryngol
Schalk P et al. (2018) Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study. Support Care Cancer
Cohn ZJ, Kim A, Huang L, Brand J, Wang H (2010) Lipopolysaccharide-induced inflammation attenuates taste progenitor cell proliferation and shortens the life span of taste bud cells. BMC Neurosci
Rozengurt E, Sternini C (2007) Taste receptor signaling in the mammalian gut. Curr Opin Pharmacol
Wang J, Chen WD, Wang YD (2020) The relationship between gut microbiota and inflammatory diseases: the role of macrophages. Front Microbiol
Baj A, Moro E, Bistoletti M, Orlandi V, Crema F, Giaroni C (2019) Glutamatergic signaling along the microbiota-gut-brain axis. Int J Mol Sci
Conneely OM (2001) Antiinflammatory activities of lactoferrin. J Am Coll Nutr
Nagpal R et al. (2011) Bioactive peptides derived from milk proteins and their health beneficial potentials: an update. Food Funct
Acknowledgements
We are sincerely grateful to the patients who graciously volunteered to participate in this study; to Michele Harmon, RN, who served as the research nurse for these pilot investigations, and to Donald B. Penzien, PhD, for his time and attention as a preliminary reviewer of this manuscript.
Funding
This work was made possible through funding from the Louise McMichael Miracle Cancer Research Fund. The Virginia Tech Water INTERface Interdisciplinary Graduate Education Program provided support for Dr. Aili Wang during her PhD studies. A training grant awarded by the National Institutes of Health (NIH) Hel** to End Addiction Long-term (HEAL) Initiative and the National Cancer Institute (NCI) provided support for Dr. Megan Irby during the period of time in which this manuscript was drafted (grant number 3UG1CA189824-06S2).
Author information
Authors and Affiliations
Contributions
Dr. Glenn Lesser, Dr. Douglas Case, Dr. Aili Wang, Dr. Andrea Dietrich, and Dr. Susan Duncan contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Dr. Douglas Case, Dr. Anna Snavely, and Dr. Megan Irby. Background information was compiled and summarized by Dr. Richard Taylor and Dr. Megan Irby. The first draft of the manuscript was prepared by Dr. Megan Irby and Dr. Glenn Lesser, and all authors reviewed, revised, commented on, and drafted content for the final version of the manuscript. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Ethics approval
All procedures involving human participants were in accordance with the ethical standards of the Institutional Review Boards of Wake Forest Baptist Medical Center (CCCWFU#98112) and Virginia Tech (IRB#14–880) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The studies described in this manuscript are registered with www.clinicaltrials.gov (NCT01596634; NCT01941810).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent for publication
Patients signed informed consent regarding publishing of data derived from the studies described within this manuscript.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lesser, G.J., Irby, M.B., Taylor, R.C. et al. Lactoferrin supplementation for taste and smell abnormalities among patients receiving cancer chemotherapy. Support Care Cancer 30, 2017–2025 (2022). https://doi.org/10.1007/s00520-021-06609-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06609-8